Country or Region |
Year |
Number tested |
% infected (1) |
Study design (2) |
Setting/comments (3, 4, 5) |
References |
|---|---|---|---|---|---|---|
Belgium |
2004 |
392 |
(4.1-6.1) |
DT |
LTS, DTC; serum |
2a, 2b, 8, 14 |
Czech Republic |
2004 |
2342 |
0.0-2.7/(0.0) |
DT; SR |
PHL, STI, ANT, OHC, PRI, HTC, DTC, LTS, STR; serum, saliva; IDUnk |
1b, 5 |
Denmark |
2004 |
106 |
4 |
SP (UAT) |
ODD; All drug related deaths which have a blood sample taken at autopsy; IDUnk |
7 |
Germany |
2004 |
990 |
3.7-3.9/(12.0) |
DT; SR |
OTH (interviews with users from the open scene), ODD (drug related deaths through accident, long term effects, suicide), DTC; IDUnk |
17, 22, 25, 26 |
Estonia |
2005 |
449 |
(54.3-89.9) |
SP |
LTS; dried blood spots |
4 |
Greece |
2004 |
2229 |
0.3-0.7/(0.0-0.9) |
DT |
DTC, LTS, OHC, OTH; serum |
1, 2, 9 |
Spain |
2002-03 |
18158 |
9.7-36.2/(20.8-34.9) |
DT, SP |
DTC, STI, HTC, STR; serum, dried blood spots |
1, 2, 2a, 25, 26, 28, 33 |
France |
2002-03 |
9407 |
12.2/(13.7-23.0) |
SR; SP (UAT) |
NSP, LTS, STR, DTC, GPS; IDUnk |
1, 4a, 4b, 4c, 16, 17, 18 |
Ireland |
2003 |
64 |
(12.5) |
SP |
DTC, serum |
14 |
Italy |
2004 |
67771 |
13.9/(1.3-39.9) |
DT |
DTC, PRI; serum, saliva; IDUnk |
1a, 1b, 30 |
Cyprus |
n.a. |
|
|
|
|
|
Latvia |
2002-03 |
1470 |
6.6-14.6/(22.0) |
DT; SP |
DTC, OHC, ARR, NSP, STR, HIV counselling centre & outreach workers; serum |
1, 4, 5, 6, 7 |
Lithuania |
2003-04 |
1722 |
2.4/(0.3-0.4) |
DT; SP |
DTC, NSP, OHC; serum |
1, 3 |
Luxembourg |
2004 |
196 |
5.1 |
SR |
DTC, LTS, OHC, PRI, Judicial Police |
1c, 1e |
Hungary |
2003-04 |
448 |
0.0/(0.0) |
DT; SP |
DTC, STR, PHL; serum, saliva |
1, 2 |
Malta |
2004 |
77 |
1.3 |
DT |
DTC; serum |
2 |
Netherlands |
2002 |
452 |
(9.5) |
SP |
DTC, STR, methadone post; saliva |
5, 10, 21 |
Austria |
2004 |
523 |
5.4/(0.0-6.3) |
DT |
LTS, PHL, GPS, HTC, DTC, ODD; serum. The national figure of 5.4 % is a lower bound of prevalence estimate due to missing values. |
1, 1a, 2, 3, 4, 5 |
Poland |
2004 |
418 |
(8.9-16.0) |
SP |
DTC, LTS, STR; serum |
5 |
Portugal |
2004 |
9074 |
12.0-19.2 |
DT |
DTC, Detoxification units, Outpatient units, Therapeutic communities, Public detoxification units; serum, dried blood spots; IDUnk |
10a, 23, 24 |
Slovenia |
2003-04 |
857 |
0.4/(0.0) |
DT; SP (UAT) |
NSP, DTC; saliva, serum |
1, 2 |
Slovakia |
2003-04 |
1036 |
(0.0) |
DT |
DTC |
3, 4, 7 |
Finland |
2003-04 |
1454 |
(0.0-2.7) |
DT; SP (UAT) |
NSP; serum, saliva |
6 |
Sweden |
n.a. |
|
|
|
|
|
United Kingdom |
2003-04 |
4632 |
(0.3-3.9) |
DT; SP (UAT) |
DTC, NSP, LTS, PHL, primary care and outreach, named HIV tests; saliva, serum |
5, 9, 20, 29, 31 |
Bulgaria |
2004 |
1203 |
(0.7) |
DT |
DTC, NSP; serum |
1a, 1b |
Romania |
2004 |
173 |
(0.0-1.1) |
DT; SP |
DTC; serum |
2 |
Turkey |
2004 |
38 |
(0.0) |
DT |
DTC; serum |
1 |
Norway |
2004 |
264 |
(0.4) |
SP |
NSP, STR; serum |
2, 2a, 2b |
Notes: This summary table intends to give a global overview of HIV prevalence in IDUs in the EU. In this table data are reported for the most recent year available. Data sources for more than one year are used if they clearly improve generalisability (e.g. national data, out-of-treatment data). Prevalence in this table should not be compared with previous versions to follow changes over time, as inclusion of sources may vary according to data availability. For time trends see Table INF-8 to Table INF-10. n.a. = not available (1) The figures given in brackets show local estimates (or range of estimates) within the country. (2) Self-reported test results are less reliable than biological test results. (3) Having health problems is one selection criterion for admission to drug treatment in some countries or cities (Greece, Portugal, Rome), due to long waiting lists or special programmes for infected IDUs, and this may result in upward bias of prevalence. Prevalence from treatment data should therefore be interpreted in combination with non-treatment data. On the other hand, data from Italy and Portugal include non-IDUs and may thus underestimate prevalence in IDUs. (4) IDUnk = IDU not known, prevalence may be too low. (5) ODD = Overdose Deaths; DEM = Drug Emergencies; DTC = Drug Treatment Centres; NSP = Needle Exchanges; LTS = Low-Threshold Services; PHL = Public Health Laboratories; STI = STI Clinics; ANT = Antenatal Clinics; OHC = Other Hospital or Clinics; PRI = Prisons; ARR = Arrests; GPS = General Practitioners; HTC = HIV Testing Centres; STR = Street; OTH = Other. See also 'General notes for interpreting data' on the Explanatory notes and help page. Sources: See Table INF-8 (Excel format). | ||||||